Pyxis Oncology, Inc. (PYXS) Current Reports & Earnings Releases
Upcoming
- 2026-11-02 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-13 | 8-K | Results of Operations | SEC |
| 2026-07-02 | 8-K | Material Agreement, Unregistered Sales, Reg FD Disclosure | SEC |
| 2026-06-15 | 8-K | Shareholder Vote Results | SEC |
| 2026-05-14 | 8-K | Results of Operations | SEC |
| 2026-03-23 | 8-K | Results of Operations, Reg FD Disclosure | SEC |
| 2026-02-06 | 8-K | Financial Statements & Exhibits | SEC |
| 2025-12-18 | 8-K | Reg FD Disclosure, Other Events | SEC |
| 2025-11-03 | 8-K | Results of Operations | SEC |
| 2025-08-14 | 8-K | Results of Operations | SEC |
| 2025-08-04 | 8-K | Other Events | SEC |
| 2025-07-03 | 8-K | Officer / Director Changes | SEC |
| 2025-06-18 | 8-K | Shareholder Vote Results | SEC |
| 2025-05-15 | 8-K | Results of Operations, Reg FD Disclosure | SEC |
| 2025-03-24 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-03-18 | 8-K | Results of Operations, Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-02-26 | 8-K | Other Events | SEC |
| 2025-02-04 | 8-K | Other Events | SEC |
| 2024-12-19 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-11-20 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-11-12 | 8-K | Results of Operations | SEC |
| 2024-10-23 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-08-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-06-12 | 8-K | Shareholder Vote Results | SEC |
| 2024-06-10 | 8-K | Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-05-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-03-27 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-03-27 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-03-21 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-03-13 | 8-K | Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-02-28 | 8-K | Material Agreement, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.